Showing 9,301 - 9,320 results of 31,218 for search '(( 50 ((we decrease) OR (a decrease)) ) OR ( 100 ((ng decrease) OR (mean decrease)) ))', query time: 1.15s Refine Results
  1. 9301

    Image_5_Is Proton Therapy a “Pro” for Breast Cancer? A Comparison of Proton vs. Non-proton Radiotherapy Using the National Cancer Database.pdf by Mudit Chowdhary (6016496)

    Published 2019
    “…On multivariate logistic analysis, the following factors were found to be significant for receipt of PRT (all p < 0.05): academic facility (odds ratio [OR] = 2.50), South (OR = 2.01) and West location (OR = 12.43), left-sided (OR = 1.21), ER-positive (OR = 1.59), and mastectomy (OR = 1.47); pT2-T4 disease predicted for decrease use (OR = 0.79). …”
  2. 9302

    Table_1_Is Proton Therapy a “Pro” for Breast Cancer? A Comparison of Proton vs. Non-proton Radiotherapy Using the National Cancer Database.DOCX by Mudit Chowdhary (6016496)

    Published 2019
    “…On multivariate logistic analysis, the following factors were found to be significant for receipt of PRT (all p < 0.05): academic facility (odds ratio [OR] = 2.50), South (OR = 2.01) and West location (OR = 12.43), left-sided (OR = 1.21), ER-positive (OR = 1.59), and mastectomy (OR = 1.47); pT2-T4 disease predicted for decrease use (OR = 0.79). …”
  3. 9303

    Image_4_Is Proton Therapy a “Pro” for Breast Cancer? A Comparison of Proton vs. Non-proton Radiotherapy Using the National Cancer Database.pdf by Mudit Chowdhary (6016496)

    Published 2019
    “…On multivariate logistic analysis, the following factors were found to be significant for receipt of PRT (all p < 0.05): academic facility (odds ratio [OR] = 2.50), South (OR = 2.01) and West location (OR = 12.43), left-sided (OR = 1.21), ER-positive (OR = 1.59), and mastectomy (OR = 1.47); pT2-T4 disease predicted for decrease use (OR = 0.79). …”
  4. 9304

    Image_3_Is Proton Therapy a “Pro” for Breast Cancer? A Comparison of Proton vs. Non-proton Radiotherapy Using the National Cancer Database.pdf by Mudit Chowdhary (6016496)

    Published 2019
    “…On multivariate logistic analysis, the following factors were found to be significant for receipt of PRT (all p < 0.05): academic facility (odds ratio [OR] = 2.50), South (OR = 2.01) and West location (OR = 12.43), left-sided (OR = 1.21), ER-positive (OR = 1.59), and mastectomy (OR = 1.47); pT2-T4 disease predicted for decrease use (OR = 0.79). …”
  5. 9305

    Image_2_Is Proton Therapy a “Pro” for Breast Cancer? A Comparison of Proton vs. Non-proton Radiotherapy Using the National Cancer Database.pdf by Mudit Chowdhary (6016496)

    Published 2019
    “…On multivariate logistic analysis, the following factors were found to be significant for receipt of PRT (all p < 0.05): academic facility (odds ratio [OR] = 2.50), South (OR = 2.01) and West location (OR = 12.43), left-sided (OR = 1.21), ER-positive (OR = 1.59), and mastectomy (OR = 1.47); pT2-T4 disease predicted for decrease use (OR = 0.79). …”
  6. 9306

    Image_1_Is Proton Therapy a “Pro” for Breast Cancer? A Comparison of Proton vs. Non-proton Radiotherapy Using the National Cancer Database.pdf by Mudit Chowdhary (6016496)

    Published 2019
    “…On multivariate logistic analysis, the following factors were found to be significant for receipt of PRT (all p < 0.05): academic facility (odds ratio [OR] = 2.50), South (OR = 2.01) and West location (OR = 12.43), left-sided (OR = 1.21), ER-positive (OR = 1.59), and mastectomy (OR = 1.47); pT2-T4 disease predicted for decrease use (OR = 0.79). …”
  7. 9307

    Esculetin, a coumarin derivative, exerts in vitro and in vivo antiproliferative activity against hepatocellular carcinoma by initiating a mitochondrial-dependent apoptosis pathway by J. Wang (472325)

    Published 2019
    “…Esculetin significantly inhibited proliferation of HCC cells in a concentration- and time-dependent manner and with an IC50 value of 2.24 mM. …”
  8. 9308

    A regulatory gene network of foam-cell formation. by Josefin Skogsberg (88384)

    Published 2008
    “…CE accumulation (given as average percentage next to each node) was decreased (blue) by siRNA inhibition of 5 genes and increased (red) by inhibition of 2 genes; inhibition of 1 gene had no effect (black) (see also <a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1000036#pgen-1000036-t003" target="_blank">Table 3</a>). …”
  9. 9309
  10. 9310
  11. 9311

    The impact of the single exit price policy on a basket of generic medicines in South Africa, using a time series analysis from 1999 to 2014 by Rajatheran Moodley (7109351)

    Published 2019
    “…</p><p>Results</p><p>Majority of the medicines analysed reflect a substantial decrease in medicine prices immediately after implementation of the pricing regulations as reflected in both the change in level and the change in slope using the interrupted time series analysis.…”
  12. 9312
  13. 9313

    Establishment and characterization of a choroid plexus barrier system. by Bethany A. O’Hara (8532741)

    Published 2024
    “…<p>A) Barrier development protocol. Cells are maintained at high density (>50% confluence) and used for experiments between passages 30–38. …”
  14. 9314

    RovA stimulated transcription of its own gene. by Yiquan Zhang (113213)

    Published 2011
    “…<p>Only the bacterial cells of “shift from 26 to 37°C” at the middle-exponential growth phase were analyzed herein. <b>a) LacZ fusion.</b> A promoter-proximal region 743 bp upstream to 146 bp downstream of <i>rovA</i> was cloned into pRW50 containing a promoterless <i>lacZ</i> reporter gene, and then transformed into WT or <i>ΔrovA</i> to determine the β-galactosidase activity in cellular extracts. …”
  15. 9315

    Change in smooth muscle NO from a dynamic increase in flow. by William Davis Haselden (9175156)

    Published 2020
    “…<p>Simulations were performed using a static proximal model with a NO production rate in the parenchyma of 0.02 M/s corresponding to 50% GC activity with no flow. …”
  16. 9316

    The physiological role of I<sub>Cl(Ca)</sub> during membrane depolarization was examined using NPPB and T16A<sub>inh</sub>-A01. by Ji Hyun Jeon (112239)

    Published 2013
    “…The half-maximal dose (EC<sub>50</sub>) of T16A<sub>inh</sub>-A01 that was necessary to increase the width was similar to EC<sub>50</sub> of T16A<sub>inh</sub>-A01 that inhibited I<sub>Cl(Ca)</sub> (2.6 vs. 3.0 µM). …”
  17. 9317
  18. 9318
  19. 9319
  20. 9320